This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Vermeer, M. H. Articles by Tensen, C. P. PubMed PubMed Citation Articles by Vermeer, M. H. Articles by Tensen, C. P.

Novel and Highly Recurrent Chromosomal Alterations in Sézary Syndrome

Departments of ¹ Dermatology and ² Molecular Cell Biology, Leiden University Medical Center, Leiden, the Netherlands; ³ Department of Dermatology, St Thomas' Hospital, King's College, London, United Kingdom; ⁴ Department of Dermatology, University Medical Center Groningen, Groningen, the Netherlands; ⁵ Department of Dermatology, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands; ⁶ Department of Dermatology, Gent University Hospital, Gent, Belgium; ⁷ Department of Dermatology, Charite, Berlin, Germany; and ⁸ Department of Genetics and Pathology, Rudbeck Laboratory, University of Uppsala, Uppsala, Sweden

Requests for reprints: Cornelis P. Tensen, Department of Dermatology, T02-03, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, the Netherlands. Phone: 31-71-526-9369; Fax: 31-71-524-8106; E-mail: c.p.tensen{at}lumc.nl.

Key Words: array-based comparative genomic hybridization • Molecular genetics • Sézary syndrome

This study was designed to identify highly recurrent genetic alterations typical of Sézary syndrome (Sz), an aggressive cutaneous T-cell lymphoma/leukemia, possibly revealing pathogenetic mechanisms and novel therapeutic targets. High-resolution array-based comparative genomic hybridization was done on malignant T cells from 20 patients. Expression levels of selected biologically relevant genes residing within loci with frequent copy number alteration were measured using quantitative PCR. Combined binary ratio labeling-fluorescence in situ hybridization karyotyping was done on malignant cells from five patients. Minimal common regions with copy number alteration occurring in at least 35% of patients harbored 15 bona fide oncogenes and 3 tumor suppressor genes. Based on the function of the identified oncogenes and tumor suppressor genes, at least three molecular mechanisms are relevant in the pathogenesis of Sz. First, gain of cMYC and loss of cMYC antagonists (MXI1 and MNT) were observed in 75% and 40% to 55% of patients, respectively, which were frequently associated with deregulated gene expression. The presence of cMYC/MAX protein heterodimers in Sézary cells was confirmed using a proximity ligation assay. Second, a region containing TP53 and genome maintenance genes (RPA1/HIC1) was lost in the majority of patients. Third, the interleukin 2 (IL-2) pathway was affected by gain of STAT3/STAT5 and IL-2 (receptor) genes in 75% and 30%, respectively, and loss of TCF8 and DUSP5 in at least 45% of patients. In sum, the Sz genome is characterized by gross chromosomal instability with highly recurrent gains and losses. Prominent among deregulated genes are those encoding cMYC, cMYC-regulating proteins, mediators of MYC-induced apoptosis, and IL-2 signaling pathway components. [Cancer Res 2008;68(8):2689–98]